Sun Pharmaceutical (SUNPHARMA) — Announcement

📢 Key Event
Sun Pharma secures Brazil approval for semaglutide launch

🔮 What's Next
launch in the next few days

💡 Investor Takeaway
This approval opens a new revenue stream in Brazil's diabetes market.

Sun Pharmaceutical Industries Limited announced that it has received approval from Brazil's ANVISA to manufacture and market semaglutide injection for type 2 diabetes, partnering with Hypera Pharma for a near-term launch in Brazil.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"When will semaglutide generate revenue?" "What is the revenue share with Hypera Pharma?" "How does this affect Sun Pharma's diabetes portfolio growth?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 29 July 2026

SUZLON Suzlon Energy Limited Corporate Action DABUR Dabur India Limited Financial Results SYRMA Syrma SGS Technology Limited Financial Results KROSS Kross Limited Financial Results ASIANPAINT Asian Paints Limited Financial Results CREDITACC CREDITACCESS GRAMEEN LIMITED Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.